$GLUC Celsius Holdings, Inc. Former CEO Gerry David Joins

New Post Public Reply Private Reply Replies (0) Message Board
hotforpenny
365
$GLUC Celsius Holdings, Inc. Former CEO Gerry David Joins Glucose Health, Inc.Press Release | 06/04/2019

Gerry David has accepted appointment to the Board of Directors of Glucose Health, Inc. (OTC:GLUC). For five years, Mr. David served as President and Chief Executive Officer of Celsius Holdings Inc. (NASDAQ:CELH), the manufacturer of Celsius® “negative calorie” fitness drinks. Mr. David’s many achievements during his tenure included closing $31 million in new financing which turbo-charged growth of the Celsius® brand; increased sales revenues more than five-fold and positioned Celsius Holdings Inc. to become a NASDAQ listed company with a market capitalization in excess of a quarter billion dollars.

Notable participants in the $31 million financing arranged by Mr. David, included Li Ka-Shing, the world’s 28th richest man, with a net worth of $32 billion.1 Mr. David was further responsible for placement of Celsius® with A.S. Watson Group, a division of Li Ka-Shing’s business conglomerate, CK Hutchinson Holdings. A.S. Watson Group operates 14,400 health and wellness retail locations under various store banners, including Watsons in Asia and Superdrug, the UK’s second largest pharmacy chain, after Walgreens Boots Alliance.

Gerry David, Director of Glucose Health, Inc. stated, “With my decades of experience in the nutritional beverage and supplements businesses, including with Celsius Holdings Inc. and also previously at Home Shopping Network (NASDAQ:QRTEA) and Vitarich Laboratories, I immediately recognized GlucoDown® to be a new and compelling healthy beverage choice, particularly attractive to pre-diabetics and Type-2 diabetics. But it was when I received my container of GlucoDown® and tasted the product, that I was truly sold. GlucoDown® is as good, if not better tasting, than any flavored iced tea on the market today. Combine this great iced tea taste with dozens of clinical studies supporting the health benefits of the active ingredients in GlucoDown® and it all adds up to a powerful new functional beverage product. The impressive sales of GlucoDown® in-store at Walmart and at Amazon recently are no surprise to me and I am excited by my opportunity to accelerate growth of the brand and contribute to the success of Glucose Health, Inc.”

About Glucose Health, Inc. (OTC:GLUC)

GLUCODOWN® is the premier functional beverage in the diabetic nutritional consumer category, which encompasses the more than 100 million Americans estimated to be diabetic or pre-diabetic, by the Centers for Disease Control and Prevention.2 GLUCODOWN® is the first tea mix ever enriched with healthy soluble fiber. GLUCODOWN® is proudly manufactured in the USA in Arkansas and Minnesota. Glucose Health, Inc. is a publicly-traded company with the ticker symbol (OTC:GLUC).

1 Forbes, February 19, 2019

2 National Diabetes Statistics Review, 2017; Centers for Disease Control and Prevention, Department of Health and Human Services.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190604005260/en/

Glucose Health, Inc. (GLUC) Stock Research Links

GLUC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 24

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 28

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 18

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 46

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 30

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Gene-Editing Therapy CS-121 Revolutionizes Hyperlipidemia Treatment

Updated Category News Views 232

Transformative Progress in Gene-Editing Therapies CorrectSequence Therapeutics Co., Ltd. is at the forefront of biotechnology innovation with its promising gene-editing therapy, CS-121, designed to tackle chylomicronemia and hypertriglyceridemia. This breakthrough comes as an exciting advancement in the medical field, particularly for patients suffering from severe lipid...

Continue Reading
Blue Ridge Partners Showcases Expertise at PEI Forum Europe

Updated Category News Views 211

Blue Ridge Partners Takes Center Stage at Key Forum Blue Ridge Partners, a leading global management consultancy, will serve as the Knowledge Partner for a significant upcoming event in the private equity sector. The firm is excited to announce its role in the 2025 PEI Operating Partners Forum Europe, taking place in May. Over a decade of collaboration as the Knowledge...

Continue Reading
Alger Russell Innovation Index Q4 2025 Rebalancing Insights

Updated Category News Views 81

Alger Russell Innovation Index Changes for Q4 2025 Fred Alger Management, LLC, a notable growth equity investment manager, has announced significant updates to the Alger Russell Innovation Index. This announcement concerns the quarterly rebalancing that will take place after the trading session concludes. These changes reflect the ever-evolving landscape of investment...

Continue Reading
Partners Value Split Corp. Announces Redemption of Shares

Updated Category News Views 205

Partners Value Split Corp. to Redeem Class AA Preferred Shares Recently, Partners Value Split Corp. (the “Company”) shared exciting news regarding its Class AA Preferred Shares, Series 9. This announcement indicates the Company’s intention to redeem all of its outstanding 5,996,800 Preferred Shares, Series 9 for cash, in accordance with the established terms....

Continue Reading
Pagos' MCP Server: The Future of Payment Data Access?

Updated Category News Views 160

Pagos unveiled a significant upgrade to its Model Context Protocol (MCP) Server on February 17, 2026. This expansion aims to revolutionize how merchants access and analyze their verified payments data directly via AI chat agents like ChatGPT and Claude. Traders in the fintech space are already sizing up this move, pondering whether it marks a genuine leap forward or just...

Continue Reading